New drug aims to tame dangerous fat levels in blood
NCT ID NCT05852431
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called pegozafermin in 369 adults with severe hypertriglyceridemia, a condition where blood fat levels are dangerously high. Participants received either the drug or a placebo for 26 weeks. The main goal was to see if the drug could safely lower triglyceride levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pegozafermin
What this could lead to
If it works, this could provide a new treatment option to lower dangerously high triglycerides and reduce the risk of pancreatitis and heart disease.
What could go wrong
This is a completed Phase 3 trial, but results are not yet public. The drug may not work better than placebo, and side effects are possible with any new medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
89 Clinical Study Site
Austin, Texas, 78757, United States
-
89Bio Clinical Study Site
Tucson, Arizona, 85712, United States
-
89Bio Clinical Study Site
Long Beach, California, 90815, United States
-
89Bio Clinical Study Site
Tustin, California, 92780, United States
-
89Bio Clinical Study Site
Clearwater, Florida, 33756, United States
-
89Bio Clinical Study Site
Homestead, Florida, 33030, United States
-
89Bio Clinical Study Site
Miami Lakes, Florida, 33014, United States
-
89Bio Clinical Study Site
Orlando, Florida, 32825, United States
-
89Bio Clinical Study Site
Tampa, Florida, 33606, United States
-
89Bio Clinical Study Site
Columbus, Georgia, 31904, United States
-
89Bio Clinical Study Site
Lawrenceville, Georgia, 30044, United States
-
89Bio Clinical Study Site
Chicago, Illinois, 60607, United States
-
89Bio Clinical Study Site
Wichita, Kansas, 67205, United States
-
89Bio Clinical Study Site
Marrero, Louisiana, 70072, United States
-
89Bio Clinical Study Site
Oxon Hill, Maryland, 20745, United States
-
89Bio Clinical Study Site
North Massapequa, New York, 11758, United States
-
89Bio Clinical Study Site
Morganton, North Carolina, 28655, United States
-
89Bio Clinical Study Site
Eugene, Oregon, 97404, United States
-
89Bio Clinical Study Site
Chattanooga, Tennessee, 37421, United States
-
89Bio Clinical Study Site
Lampasas, Texas, 76550, United States
-
89Bio Clinical Study Site
Burke, Virginia, 22015, United States
-
89Bio Clinical Study Site
San Juan, 00927, Puerto Rico
-
89bio Clincal Study Site
London, N128BU, United Kingdom
-
89bio Clinical Study Site
Chandler, Arizona, 85712, United States
-
89bio Clinical Study Site
Peoria, Arizona, 85381, United States
-
89bio Clinical Study Site
Conway, Arkansas, 72032, United States
-
89bio Clinical Study Site
Jonesboro, Arkansas, 72401, United States
-
89bio Clinical Study Site
Little Rock, Arkansas, 72205, United States
-
89bio Clinical Study Site
Los Angeles, California, 90057, United States
-
89bio Clinical Study Site
Santa Ana, California, 92705, United States
-
89bio Clinical Study Site
Thousand Oaks, California, 91360, United States
-
89bio Clinical Study Site
Wheat Ridge, Colorado, 80033, United States
-
89bio Clinical Study Site
Bridgeport, Connecticut, 06610, United States
-
89bio Clinical Study Site
Clearwater, Florida, 33761, United States
-
89bio Clinical Study Site
Hialeah Gardens, Florida, 33016, United States
-
89bio Clinical Study Site
Miramar, Florida, 33027, United States
-
89bio Clinical Study Site
Panama City, Florida, 32401, United States
-
89bio Clinical Study Site
Atlanta, Georgia, 30309, United States
-
89bio Clinical Study Site
West Des Moines, Iowa, 50265, United States
-
89bio Clinical Study Site
Flint, Michigan, 48504, United States
-
89bio Clinical Study Site
St Louis, Missouri, 63110, United States
-
89bio Clinical Study Site
Las Vegas, Nevada, 89106, United States
-
89bio Clinical Study Site
Las Vegas, Nevada, 89118, United States
-
89bio Clinical Study Site
East Syracuse, New York, 13057, United States
-
89bio Clinical Study Site
Cincinnati, Ohio, 45227, United States
-
89bio Clinical Study Site
Middleburg Heights, Ohio, 44130, United States
-
89bio Clinical Study Site
Stow, Ohio, 44224, United States
-
89bio Clinical Study Site
Oklahoma City, Oklahoma, 73102, United States
-
89bio Clinical Study Site
Charleston, South Carolina, 29414, United States
-
89bio Clinical Study Site
Tullahoma, Tennessee, 37388, United States
-
89bio Clinical Study Site
Amarillo, Texas, 79106, United States
-
89bio Clinical Study Site
Dallas, Texas, 75226, United States
-
89bio Clinical Study Site
Graham, Texas, 76450, United States
-
89bio Clinical Study Site
Houston, Texas, 77030, United States
-
89bio Clinical Study Site
Mansfield, Texas, 76063, United States
-
89bio Clinical Study Site
San Antonio, Texas, 78209, United States
-
89bio Clinical Study Site
Wichita Falls, Texas, 76301, United States
-
89bio Clinical Study Site
Rosario, Santa Fe Province, 2000, Argentina
-
89bio Clinical Study Site
Buenos Aires, C1023AAB, Argentina
-
89bio Clinical Study Site
Buenos Aires, C1425CABA, Argentina
-
89bio Clinical Study Site
Buenos Aires, C1426ABP, Argentina
-
89bio Clinical Study Site
Córdoba, 5000, Argentina
-
89bio Clinical Study Site
Córdoba, 5749, Argentina
-
89bio Clinical Study Site
Córdoba, X5000 BSQ, Argentina
-
89bio Clinical Study Site
Córdoba, X5000AAX, Argentina
-
89bio Clinical Study Site
Córdoba, X5004CDT, Argentina
-
89bio Clinical Study Site
Mendoza, M5509, Argentina
-
89bio Clinical Study Site
Rosario, S2000CVD, Argentina
-
89bio Clinical Study Site
San Miguel de Tucumán, T400IHE, Argentina
-
89bio Clinical Study Site
Viedma, R8500ACE, Argentina
-
89bio Clinical Study Site
Graz, A-8036, Austria
-
89bio Clinical Study Site
Edegem, 2650, Belgium
-
89bio Clinical Study Site
Ghent, 9000, Belgium
-
89bio Clinical Study Site
Haine-Saint-Paul, 7100, Belgium
-
89bio Clinical Study Site
Yvoir, 5530, Belgium
-
89bio Clinical Study Site
Dimitrovgrad, 6400, Bulgaria
-
89bio Clinical Study Site
Sliven, 8800, Bulgaria
-
89bio Clinical Study Site
Sofia, 1336, Bulgaria
-
89bio Clinical Study Site
Sofia, 1431, Bulgaria
-
89bio Clinical Study Site
Sofia, 1606, Bulgaria
-
89bio Clinical Study Site
Sofia, 1618, Bulgaria
-
89bio Clinical Study Site
Veliko Tarnovo, 5000, Bulgaria
-
89bio Clinical Study Site
North Vancouver, British Columbia, V7M 2H4, Canada
-
89bio Clinical Study Site
Brampton, Ontario, L6R3J7, Canada
-
89bio Clinical Study Site
Chicoutimi, Quebec, G7H 7K9, Canada
-
89bio Clinical Study Site
Laval, Quebec, H7T2P5, Canada
-
89bio Clinical Study Site
Montreal, Quebec, H2W1R7, Canada
-
89bio Clinical Study Site
Québec, Quebec, G1V 4G5, Canada
-
89bio Clinical Study Site
Concepción, 4030000, Chile
-
89bio Clinical Study Site
Santiago, 8330336, Chile
-
89bio Clinical Study Site
Santiago, 8910259, Chile
-
89bio Clinical Study Site
Valdivia, 5090000, Chile
-
89bio Clinical Study Site
Viña del Mar, 2520997, Chile
-
89bio Clinical Study Site
Brno, 60200, Czechia
-
89bio Clinical Study Site
Brno, 65691, Czechia
-
89bio Clinical Study Site
Prague, 12808, Czechia
-
89bio Clinical Study Site
Prague, 14021, Czechia
-
89bio Clinical Study Site
Prague, 15006, Czechia
-
89bio Clinical Study Site
Marseille, 13005, France
-
89bio Clinical Study Site
Paris, 75013, France
-
89bio Clinical Study Site
Valenciennes, 59300, France
-
89bio Clinical Study Site
Batumi, 6000, Georgia
-
89bio Clinical Study Site
Tbilisi, 0160, Georgia
-
89bio Clinical Study Site
Tbilisi, 0177, Georgia
-
89bio Clinical Study Site
Tbilisi, 0186, Georgia
-
89bio Clinical Study Site
Essen, 45147, Germany
-
89bio Clinical Study Site
Leipzig, 27 04103, Germany
-
89bio Clinical Study Site
Baja, Hungary
-
89bio Clinical Study Site
Nyíregyháza, 4400, Hungary
-
89bio Clinical Study Site
Belagāve, 590010, India
-
89bio Clinical Study Site
Bīkaner, 334001, India
-
89bio Clinical Study Site
Dehradun, 248001, India
-
89bio Clinical Study Site
Jaipur, 302017, India
-
89bio Clinical Study Site
Nagpur, 441108, India
-
89bio Clinical Study Site
Pimpri-Chinchwad, 411057, India
-
89bio Clinical Study Site
Varanasi, 221010, India
-
89bio Clinical Study Site
Milan, 20138, Italy
-
89bio Clinical Study Site
Modena, 41126, Italy
-
89bio Clinical Study Site
Reggio Emilia, 42123, Italy
-
89bio Clinical Study Site
Daugavpils, Latvia
-
89bio Clinical Study Site
Zemgale, 1002, Latvia
-
89bio Clinical Study Site
Monterrey, Nuevo León, 64310, Mexico
-
89bio Clinical Study Site
Cuernavaca, Mexico
-
89bio Clinical Study Site
General Escobedo, 66050, Mexico
-
89bio Clinical Study Site
Guadalajara, 76100, Mexico
-
89bio Clinical Study Site
Querétaro City, 76100, Mexico
-
89bio Clinical Study Site
Tlalpan, 14080, Mexico
-
89bio Clinical Study Site
Bialystok, 15-351, Poland
-
89bio Clinical Study Site
Krakow, 30-348, Poland
-
89bio Clinical Study Site
Krakow, 31-501, Poland
-
89bio Clinical Study Site
Lodz, 91-363, Poland
-
89bio Clinical Study Site
Lodz, 93-338, Poland
-
89bio Clinical Study Site
Lublin, 20-362, Poland
-
89bio Clinical Study Site
Warsaw, 00-215, Poland
-
89bio Clinical Study Site
Barcelona, 08036, Spain
-
89bio Clinical Study Site
Barcelona, 08041, Spain
-
89bio Clinical Study Site
Barcelona, 08907, Spain
-
89bio Clinical Study Site
Cadiz, 11009, Spain
-
89bio Clinical Study Site
Córdoba, 14004, Spain
-
89bio Clinical Study Site
Granada, 18014, Spain
-
89bio Clinical Study Site
Granada, 18016, Spain
-
89bio Clinical Study Site
Huelva, 21005, Spain
-
89bio Clinical Study Site
Madrid, 28041, Spain
-
89bio Clinical Study Site
Málaga, 29004, Spain
-
89bio Clinical Study Site
Pamplona, 31008, Spain
-
89bio Clinical Study Site
Cardiff, CF14 4XW, United Kingdom
-
89bio Clinical Study Sites
Sparta, New Jersey, 07871, United States
-
89bio Clinical Trial Site
Huntington Park, California, 90255, United States
-
89bio Clinical Trial Site
Northridge, California, 91325, United States
-
89bio Clinical Trial Site
Panorama City, California, 91402, United States
-
89bio Clinical Trial Site
Santa Ana, California, 92705, United States
-
89bio Clinical Trial Site
Wheat Ridge, Colorado, 80033, United States
-
89bio Clinical Trial Site
Port Orange, Florida, 32127, United States
-
89bio Clinical Trial Site
Shreveport, Louisiana, 71105, United States
-
89bio Clinical Trial Site
Kansas City, Missouri, 64131, United States
-
89bio Clinical Trial Site
New Windsor, New York, 12553, United States
-
89bio Clinical Trial Site
New York, New York, 10029, United States
-
89bio Clinical Trial Site
Richmond Hill, New York, 77379, United States
-
89bio Clinical Trial Site
Syracuse, New York, 13057, United States
-
89bio Clinical Trial Site
Columbus, Ohio, 43213, United States
-
89bio Clinical Trial Site
Clarksville, Tennessee, 37040, United States
-
89bio Clinical Trial Site
San Antonio, Texas, 78207, United States
-
89bio Clinical Trial Site
Salt Lake City, Utah, 84107, United States
-
89bio Clinical Trial Site
Richmond, Virginia, 23249, United States
-
89bio Clinical Trial Site
Vienna, 1030, Austria
-
89bio Clinical Trial Site
Vienna, 1130, Austria
-
89bio Clinical Trial Site
Botevgrad, 2140, Bulgaria
-
89bio Clinical Trial Site
Plovdiv, 4004, Bulgaria
-
89bio Clinical Trial Site
Sliven, 8800, Bulgaria
-
89bio Clinical Trial Site
Sofia, 1202, Bulgaria
-
89bio Clinical Trial Site
Veliko Tarnovo, 5000, Bulgaria
-
89bio Clinical Trial Site
Kutaisi, 4600, Georgia
-
89bio Clinical Trial Site
Tbilisi, 0159, Georgia
-
89bio Clinical Trial Site
Balatonfüred, 8230, Hungary
-
89bio Clinical Trial Site
Budapest, 1122, Hungary
-
89bio Clinical Trial Site
Riga, 1002, Latvia
-
89bio Cllinical Study Site
Genova, 16132, Italy